Pharmaids Pharmaceuticals

58.80
-1.91
(-3.15%)
Market Cap
207.36 Cr
EPS
-3.56
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
87.46
52 Week Low
31.90
PB Ratio
3.61
Debt to Equity
0.09
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,667.50
#1 4,00,089.11
35.03
#1 49,887.20
12.06
#1 9,648
-18.99
40.71
6,530.00
1,73,350.98
79.22
8,184.00
0.89
1,600
23.05
59.09
1,473.20
1,18,977.83
22.51
26,520.70
14.17
4,155
30.28
46.34
3,135.00
1,06,102.65
54.96
10,785.70
11.59
1,656
10.91
40.96
1,248.30
1,04,165.06
#1 18.43
28,905.40
12.36
5,578
21.14
65.75
2,352.40
97,054.97
50.15
10,615.60
19.57
1,942
-10.91
37.13
926.40
93,217.52
20.02
19,831.50
13.82
3,831
-0.19
61.14
1,954.00
89,208.10
27.27
20,141.50
#1 19.94
1,936
#1 112.49
42.68
1,143.80
66,432.09
19.10
29,559.20
17.55
3,169
-0.50
42.85
31,135.00
66,159.70
46.07
6,097.20
10.80
1,201
27.83
58.62
Forecast
Actual
Growth Rate
Revenue Growth
15.99 %
Net Income Growth
55.26 %
Cash Flow Change
-164.18 %
ROE
-50.06 %
ROCE
-60.05 %
EBITDA Margin (Avg.)
-

Quarterly Financial Results

Quarterly Financials
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
0
0
0
0
0
0
-0
1
6
5
5
5
5
Expenses
0
1
1
9
2
2
1
3
11
8
8
8
9
EBITDA
-0
-1
-1
-9
-1
-1
-1
-2
-6
-4
-3
-3
-4
Operating Profit %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
-12,200 %
-96 %
-75 %
-50 %
-62 %
-82 %
Depreciation
0
0
0
0
0
0
0
0
1
1
1
1
1
Interest
0
0
0
0
0
0
0
0
1
0
0
1
1
Profit Before Tax
-0
-1
-1
-9
-1
-1
-1
-2
-7
-4
-4
-4
-5
Tax
0
0
0
-2
0
0
-1
-1
-1
-1
-1
-1
-1
Net Profit
-0
-1
-1
-6
-1
-1
-1
-1
-6
-3
-3
-3
-5
EPS in ₹
0.00
-0.05
-0.54
-4.76
-0.61
-0.61
-0.24
-0.54
-2.82
-0.76
-0.73
-0.55
-1.11

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
11
25
91
Fixed Assets
0
0
63
Current Assets
3
18
14
Capital Work in Progress
0
2
7
Investments
0
3
0
Other Assets
11
19
21
Total Liabilities
11
25
91
Current Liabilities
2
2
12
Non Current Liabilities
0
0
9
Total Equity
9
23
71
Reserve & Surplus
-2
1
37
Share Capital
10
21
35

Cash Flow

Cash Flow
2022
2023
2024
Net Cash Flow
0
12
-8
Investing Activities
1
-5
-75
Operating Activities
-0
-4
-11
Financing Activities
0
21
78

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Jan 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
65.81 %
65.80 %
65.65 %
55.56 %
35.44 %
20.70 %
21.08 %
16.54 %
16.45 %
9.95 %
9.94 %
9.70 %
9.25 %
5.64 %
5.64 %
5.56 %
5.19 %
5.22 %
5.22 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
33.44 %
33.19 %
33.70 %
43.47 %
63.98 %
78.72 %
74.07 %
69.78 %
69.87 %
81.71 %
81.27 %
81.93 %
60.78 %
41.06 %
41.06 %
41.14 %
41.03 %
36.42 %
36.59 %
Others
0.74 %
1.01 %
0.65 %
0.97 %
0.58 %
0.57 %
4.84 %
13.68 %
13.68 %
8.34 %
8.79 %
8.37 %
29.96 %
53.30 %
53.30 %
53.29 %
53.78 %
58.37 %
58.20 %
No of Share Holders
5,861
7,192
7,331
8,314
9,620
9,495
9,193
8,862
8,196
7,761
7,476
7,393
7,281
7,554
7,567
7,594
8,050
8,349
8,220

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
23 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 May 2025 67.93 67.72
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 73.59 68.30
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 68.56 83.30
25 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Sept 2024 45.34 39.89
31 Jan 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
31 Jan 2024 62.10 61.02
31 Dec 2022 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
31 Dec 2022 18.95 28.00

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication10 days ago
Submission Of Audited Financial Results Along With Auditors Report For The Quarter And Year Ended 31St March 2025May 23, 2025
Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended March 31St 2025May 23, 2025
Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended 31St March 2025.May 20, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 15, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2025
Intimation Of Loan AgreementMar 28, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 26, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 26, 2025
Closure of Trading WindowMar 25, 2025
Intimation Under Regulation 8(2) Of SEBI (PIT) Regulation 2015 Regarding Amendment In Fair Disclosure CodeMar 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 20, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 19, 2025
Announcement Under Regulation 30 (LODR)- Intimation On Loan AgreementFeb 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationFeb 12, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 12, 2025
Integrated Filing (Financial)Feb 12, 2025
Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 12, 2025
Board Meeting Outcome for For Declaration Of Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024Feb 12, 2025
Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024.Feb 07, 2025
Outcome Of The Circular Resolution Passed By The Board Of Directors Of The Company On February 06 2025Feb 06, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionFeb 05, 2025
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesJan 10, 2025
Draft Letter of OfferJan 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2025
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesJan 03, 2025
Detailed Public StatementJan 03, 2025
Announcement Under Regulation 30 - Intimation For Execution Of Share Purchase AgreementDec 27, 2024
Announcement under Regulation 30 (LODR)-Public Announcement-Open OfferDec 27, 2024
Public Announcement - Open OfferDec 27, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 23, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Dec 17, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Dec 16, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Dec 12, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Dec 11, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Dec 09, 2024
Intimation Of Receipt Of National GLP Certification For Material Subsidiary Of The Company.Dec 09, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Dec 06, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Dec 05, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Dec 03, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Dec 02, 2024
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.Nov 28, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2024
Announcement Under Regulation 30 - Contact Details Of KMP For Determining Materiality Of Event/ Information And Making Disclosure.Nov 13, 2024
Financial Results For The Quarter And Half Year Ended September 30, 2024Nov 13, 2024
Board Meeting Outcome for Board Meeting Outcome For Declaration Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2024.Nov 13, 2024
Announcement Under Regulation 30 (LODR) - Intimation On Loan Agreement.Nov 09, 2024
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2024.Nov 07, 2024

Technical Indicators

RSI(14)
Neutral
34.91
ATR(14)
Less Volatile
4.35
STOCH(9,6)
Oversold
15.12
STOCH RSI(14)
Oversold
0.25
MACD(12,26)
Bearish
-0.68
ADX(14)
Weak Trend
16.84
UO(9)
Bearish
33.12
ROC(12)
Downtrend And Accelerating
-9.21
WillR(14)
Oversold
-86.96